Deutsche Biotech Innovativ AG
Develops therapeutics for serious diseases using innovative blood biomarkers.
DBI | F
Overview
Corporate Details
- ISIN(s):
- DE000A0Z25L1
- LEI:
- 391200BIDNL2ZOKI1M61
- Country:
- Germany
- Address:
- Neuendorfstraße 15a, 16761 Hennigsdorf
- Website:
- https://www.dbi-ag.de/
- Sector:
- Manufacturing
Description
Deutsche Biotech Innovativ AG is a biotechnology company focused on the research and clinical development of therapeutic solutions for serious diseases. The company utilizes innovative blood biomarkers to guide its development process. Its lead product candidate is Adrecizumab, a monoclonal, adrenomedullin-specific antibody designed to treat conditions involving endothelial barrier dysfunction. Adrecizumab has completed Phase I/II clinical trials for the treatment of septic shock.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-08-19 14:00 |
Deutsche Biotech Innovativ AG: Further step towards a strong capital market ori…
|
English | 7.6 KB | ||
| 2020-08-19 09:15 |
Deutsche Biotech Innovativ AG: Erste Investition in das Biomarker-Unternehmen S…
|
German | 7.6 KB | ||
| 2020-07-21 10:00 |
Deutsche Biotech Innovativ AG: Shares admitted to Xetra trading, Baader Bank AG…
|
English | 6.2 KB | ||
| 2020-06-04 10:00 |
Deutsche Biotech Innovativ AG: Ralf M. Jakobs neuer CFO der DBI AG
|
German | 6.6 KB | ||
| 2020-03-19 00:00 |
Datum:19.03.2020
|
German | 46.9 KB | ||
| 2020-02-25 11:07 |
Deutsche Biotech Innovativ AG: Beteiligungsunternehmen AdrenoMed AG verkundet…
|
German | 6.4 KB | ||
| 2020-02-21 14:02 |
Bekanntgabe von positiven Ergebnissen der klinischen Phase II Studie AdrenOSS-2…
|
German | 4.5 KB | ||
| 2019-10-09 00:00 |
Datum:09.10.2019
|
German | 32.2 KB | ||
| 2019-09-30 13:30 |
Deutsche Biotech Innovativ AG: Beteiligungsunternehmen AdrenoMed AG
|
German | 8.5 KB | ||
| 2019-07-15 00:00 |
Datum:15.07.2019
|
German | 31.3 KB | ||
| 2019-03-22 12:30 |
Deutsche Biotech Innovativ AG: Beteiligungsunternehmen AdrenoMed AG veroffentli…
|
German | 8.3 KB | ||
| 2018-11-23 19:30 |
- Kapitalerhohung bei Tochtergesellschaft AdrenoMed AG: Mittelzufluss von rd. …
|
German | 5.4 KB | ||
| 2018-09-21 00:00 |
Datum:21.09.2018
|
German | 57.7 KB | ||
| 2018-07-31 00:00 |
Datum:31.07.2018
|
German | 29.7 KB | ||
| 2018-07-10 09:30 |
DBI AG mit Zweitlisting in Frankfurt; DBI Wechsel im Aufsichtsrat; Adrenomed: W…
|
German | 10.5 KB |
Automate Your Workflow. Get a real-time feed of all Deutsche Biotech Innovativ AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Deutsche Biotech Innovativ AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Deutsche Biotech Innovativ AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
